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Introduction
A major focus of practice-based research networks
(PBRN) is the translation of existing evidence into
clinical practice. Through the rigorous evaluation 
of methods of translating research into practice in
community settings, PBRNs have the potential to
identify and assess implementation strategies that 
are most likely to be effective and sustainable.1 Of
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ABSTRACT
Objective To determine the validity of an electronic
health record (EHR) in the identification of patients
with left ventricular dysfunction in a primary care
setting.
Design A cross-sectional study.
Setting Nine clinics participating from the
Providence Research Network (PRN) comprising
75 physicians serving approximately 200 000
patients. All clinics utilise the Logician™ EHR for 
all patient care activities.
Patients The study included all PRN patients with
an active chart.
Interventions All patients with a heart failure
diagnosis in the problem list were identified by
database query. Left ventricular ejection fraction
(LVEF) data were identified through query of local
cardiology and hospital echocardiography databases.
Additional LVEF data were sought in a manual
search of paper charts.
Measurements and main results To determine the
problem list coding accuracy for a heart failure (HF)
diagnosis we evaluated sensitivity, positive predictive
value and related derived statistical measures using
documented LVEF as the ‘gold standard’. Of 205 755
active PRN patients, 1731 were identified with a
problem list entry of HF. Based on comparison with
documented LVEF, the sensitivity for problem list
entry was 43.9% and 54.4% when HF was defined
as an LVEF 55% and 40%, respectively.
Conclusion The validity of an EHR problem list
entry of HF was poor. The problem list validity
could be enhanced through reconciliation with
other data sources. Inaccurate EHR problem lists
may have clinical consequences, including under-
prescribing of beneficial therapies.
Keywords: data quality, heart failure, medical
record system, quality improvement
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particular interest among PBRNs is the use of
information technology, such as electronic health
records (EHRs), in translating research findings into
improvements in care.
Disease states that are optimal candidates for
translational research are highly prevalent, associated
with known effective therapies and suffer from under-
treatment. Accordingly, the Providence Research
Network (PRN) teamed researchers with practising
physicians interested in improving care in the area of
heart failure.
Strategies aimed at improving heart failure manage-
ment begin with the accurate identification of candidate
patients. Commonly, identification of patient popula-
tions with a specific condition (such as heart failure
[HF]) can be accomplished by query of administrative
or claims databases. The validity of such identification
strategies can be determined using measures such as
sensitivity, specificity and predictive values. This
approach necessitates comparison of data with a ‘gold
standard’ measurement. Sources of gold standard meas-
urements include manual medical record abstraction,
patient survey and electronic databases, alone or in
combination.2–5 In one study, reliance on administra-
tive data resulted in exclusion of approximately one-
third of patients with clinical evidence of HF.6
It has been suggested that EHRs represent a source
of structured clinical data that complement or could
even replace administrative data sources for the purpose
of identifying patient populations and measuring
quality of care.7 Since the patient’s diagnosis list 
is created and maintained in the EHR by their
practitioner, it has the potential to be a very sensitive
and specific identification source. Although several
papers have described the validity of administrative
data to identify patient populations, much less is
known about the validity of EHR-derived data.8,9
Accordingly, the aim of this study was to determine
the validity of EHR for identification of patients 
with systolic dysfunction using sensitivity, positive
predictive value and related derived measures.
Methods
Study setting
The PRN is a community-based network of internal
medicine and family practice clinics in Portland,
Oregon. Network clinics participating in this study
consisted of approximately 75 primary care providers
caring for more than 200 000 patients in nine 
clinic locations. All practices share a common 
EHR, Logician™ (GE Medical Systems Information
Technology, 20540 NW Evergreen Parkway, Hillsboro,
OR 97124) that was implemented in most clinics by
1997. All office encounters and telephone contacts by
all physicians and staff are documented in the EHR 
in a text-based format. The EHR problem lists are
generated and maintained through physician entry of
patient diagnosis, analogous to the traditional paper
chart. Problem list entries are stored in a searchable
format, based on the International Classification 
of Diseases, Ninth Revision, Clinical Modification
(ICD-9-CM) system. Additional patient data, includ-
ing demographics, insurance status, medications 
and laboratory values, are available in a searchable
database. Interfaces to the EHR allow providers to
access laboratory and radiology results as well as hos-
pital and emergency room records. During the study
period external documents, such as records transferred
from previous physicians, specialty consult letters 
and non-interfaced test results, were stored in a
complementary paper chart.
The study population consists of all patients with
an active record in the PRN’s medical record database.
Patients were excluded if they left a PRN clinic or died
during the study period. Patients were defined as in-
active and were also excluded if their electronic chart
lacked documentation of any contact, including
evidence of an office visit, telephone communication
or prescription refill, between 1 January 1998 and
31 December 2000.
Methods
This study was a cross-sectional analysis comparing
patient EHRs with independently maintained cardiology
laboratory records. The study was approved by the
local institutional review board in February 2001.
Physician-entered diagnosis of HF in the EHR was
reconciled against left ventricular ejection fraction
(LVEF) as measured by echocardiography, angiography
or nuclear imaging. These measurements of LVEF were
used as the gold standard indicators for determining
whether a patient had HF due to left ventricular
dysfunction. Owing to ambiguity surrounding the
definition of systolic dysfunction, two analyses were
performed. Depressed left ventricular function was
defined as an LVEF 55% for the first analysis 
and 40% for the second. The physician-entered
diagnosis of HF was defined by the following search
terms: ICD-9-CM 402.01, 402.11, 402.91, 404.01, 404.03,
404.11, 404.13, 404.91, 404.93, 425.xx and 428.xx 
(see Table 1). At the time of this study, ICD-9-CM
codes did not support differentiation among systolic
dysfunction and other categories of HF. Accordingly,
an inclusive list of HF codes was assembled.
The gold standard measure of LVEFs was constructed
through several processes to ensure complete-
ness. First, LVEF values were extracted from the 
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echocardiography databases from all local laboratories
utilised by PRN practitioners, including hospital 
and cardiology practice laboratories. It is unlikely 
that LVEF assessment would be performed outside 
of the local laboratories. Second, manual review was
performed on all charts of patients identified with 
HF or an HF-related diagnosis in the problem list of
the patient record. Any evidence of a test yielding a
measured LVEF derived from an outside cardiology
laboratory or any results mentioned in previous chart
records or consult letters were extracted. Lastly, HF
patients who were not identified in the previous steps
were sought through a query of billing data and chart
medication lists. The practice management software
of PRN clinics was queried for evidence of billing for
a service related to any of the referenced HF-related
ICD-9-CM codes. Patients were also screened if
carvedilol was present as an active or historical
prescription in the chart medication list. Carvedilol
was selected as an identifier because it is prescribed
solely for HF. A chart review was then conducted to
confirm or exclude the presence of a depressed LVEF.
LVEF values from all of these sources were then
aggregated to create the gold standard list of patients
with confirmed systolic dysfunction. In the case of
multiple LVEF values, the lowest value was selected
for the purpose of the study.
Statistical analysis
The active population, stratified by presence or
absence of a documented chart diagnosis of HF, was
crossed with the gold standard list of patients with
confirmed systolic dysfunction. A two-by-two table
was used to calculate the following standard statistics
applicable to diagnostic tests. The EHR problem list
was treated as a diagnostic test for systolic dysfunction.
A problem list entry for HF was considered a positive
result for systolic dysfunction. Since determination 
of LVEF is a prerequisite for a diagnosis of systolic
dysfunction, the absence of an LVEF entry was defined
as a negative result.
The completeness and accuracy of the patient
problem list were inferred by measures of sensitivity
and positive predictive value, respectively.5 The
likelihood ratio for a positive result was the ratio of
the chance of a positive result if the patient had the
disease to the chance of a positive result if the disease
was absent. In addition, we report the true positive to
false negative ratio (TPFN), and the number of false
negatives to total number of patients in the database
ratio times 10 000 (DBFind10 000), which are two
newly developed and published statistical tools.5 The
DBFind10 000 represents the number of false negatives
in a database of 10 000 patients. The lower the TPFN
ratio and the higher the DBFind10 000 results, the greater
the number of false negative cases in the database.
Results
Review of all sources of measured LVEF yielded 1403
patients in the PRN with an LVEF value 55%, of
whom 793 had an LVEF 40%. The majority of LVEF
values were identified from local echocardiography
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Table 1 Frequency of heart failure-related diagnosis and ICD-9-CM codes in the PRN EHR
ICD-9-CM Description Frequency (%)
codes no.
402.01 Hypertensive heart disease, malignant with CHF 7 (0.43)
402.11 Hypertensive heart disease, benign with CHF 16 (0.92)
402.91 Hypertensive heart disease, NOS with CHF 10 (0.59)
404.01 Hypertensive heart/renal disease, malignant with CHF 1 (0.05)
404.03 Hypertensive heart/renal disease, malignant with CHF + renal failure 1 (0.05)
404.11 Hypertensive heart/renal disease, benign with CHF 0 (0)
404.13 Hypertensive heart/renal disease, benign with CHF + renal failure 2 (0.12)
404.91 Hypertensive heart/renal disease, NOS with CHF 0 (0)
404.93 Hypertensive heart/renal disease, NOS with CHF + renal failure 0 (0)
425.xx Cardiomyopathy 241 (13.92)
428.xx Heart failure 1453 (83.92)
Total 1731 (100)
NOS, not otherwise specified.
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databases (n=713), followed by manual chart review
(n=558), billing data (n=78), and carvedilol use (n=54).
The EHR database relevant to the participating PRN
clinics contained 205 755 active patient records. Of
active patient records, practitioners had entered an HF
diagnosis in the problem list of 1731 patient charts.
There were 616 patients identified with both a
problem list diagnosis of HF and a confirmed LVEF
55%. This true positive number drops to 431 when
LVEF threshold is 40%. Patients with an LVEF 55%
and 40% whose chart did not contain a problem list
entry for HF diagnosis (false negatives) totalled 787
and 362, respectively. Patients whose chart contained
an HF diagnosis but lacked documentation of depressed
LVEF were defined as false positives. Patients without
documentation of depressed LVEF either had no
evidence of LVEF assessment or a test result that
demonstrated preserved left ventricular function.
Using the 55% LVEF threshold, 214 patients had
documentation of preserved LVEF, while 902 had no
evidence of LVEF assessment. The findings for the
40% threshold were 398 and 902, respectively.
Sensitivity and positive predictive values are
variable based on the LVEF definition of systolic
dysfunction. When systolic dysfunction is defined as an
LVEF 55%, sensitivity was 43.9%, positive predictive
value was 35.5% and the likelihood ratio for a positive
result was 80.3 (see Table 2a). Comparatively, when
the LVEF definition is decreased to 40%, sensitivity
increased to 54.4%, while positive predictive value 
fell to 24.9% (see Table 2b). The likelihood ratio for a
positive result increased modestly, to 85.7. Specificity
of the EHR was 99.5% and 99.4% for an LVEF of
55% and 40% respectively, due largely to the low
prevalence of HF.
TPFN, the ratio of true positives to false negatives,
was 0.8 with an LVEF definition 55%, and increased
to 1.2 when LVEF 40%. DBFind10 000 decreased from
38.3 to 17.6 when the LVEF threshold was changed
from 55% to 40%.
Discussion
Our analysis assessed the utility of a problem list entry
for heart failure in an EHR to identify candidates 
for management of systolic dysfunction. Currently,
accurate identification of individuals with systolic
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Table 2a Results for patients with an LVEF 55%
Evidence of depressed LVEF
(LVEF 55%)
Total
Present Absent
Diagnosis of HF in problem list Present True ‘+’ (A) False ‘+’ (B) (A + B)
616 1116 1732
Absent False ‘–’ (C) True ‘–’ (D) (C + D)
787 203 237 204 024
Total (A + C) (B + D) (A + B + C + D)
1403 204 353 205 756
95% Confidence interval
Sensitivity A/(A+C) 43.9% 43.7%–44.1%
Specificity D/(B+D) 99.5% 99.4%–99.5%
Likelihood ratio ‘+’ 80.3
Likelihood ratio ‘–’ 0.6
Positive predictive value A/(A+B) 35.5% 35.4%–35.8%
Negative predictive value D/(C+D) 99.6% 99.6%–99.6%
TPFN ratio 0.8
DBFind10 000 38.3
LVEF = left ventricular ejection fraction
TPFN = true positive to false negative
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dysfunction for the purpose of providing targeted
interventions is a difficult task. Structured medical
data stored by an EHR may be expected to complement
other data sources for a variety of uses, including
quality improvement processes, disease management
programmes and clinical research. Validation of the
accuracy of EHR patient problem lists not only describes
current physician practice, but is also a prerequisite 
in defining the broader utility of this information
source. It has been suggested that the validity of these
data is best characterised by statistical measures often
applied to diagnostic tests, such as sensitivity, positive
predictive value and likelihood ratios.5 This study
characterises the utility of a problem list database for
identification of candidates for heart failure disease
management interventions among 205 755 patients in
a community-based primary care PBRN.
Sensitivity and positive predictive value were
dependent upon the LVEF value used to define
systolic dysfunction, and are reported here for LVEF
thresholds of 40% and 55%. In both cases sensitivity
and positive predictive value are disappointing. The
sensitivity of 54.4%, obtained even with the LVEF
threshold set at 40%, implies that nearly half of the
systolic dysfunction population would be overlooked
using this search strategy. Likewise, the positive
predictive value of 24.9%, determined at the same
LVEF threshold, implies that a patient with a problem
list entry for HF has only a one-quarter likelihood of
documented systolic dysfunction.
The results of the derived statistics TPFN ratio and
DBFind10 000 also suggest poor validity of the problem
list database. The latter statistic represents the number
of false negatives in a database of 10 000 patients, and
can therefore be used to quantify and compare the
potential benefit of reconciliation of the database.
Thus, with validation of the database one could expect
to identify 17–38 additional patients with systolic
dysfunction in every 10 000 patients.
These results are of increasing value based on the
increasing prevalence of EHR use and the comparable
processes for physician entry of diagnosis that exist
across EHR types. However, the findings may not be
reflective of data accuracy in countries such as the
United Kingdom with a 99% prevalence of EHRs in
primary care together with dedicated efforts to im-
prove data quality and information management.10,11
The search capability of the EHR offers potential new
uses for medical record data, including problem lists.
One source of problem list inaccuracy may relate to
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Table 2b Results for patients with an LVEF 40%
Evidence of depressed LVEF
(LVEF 40%)
Total
Present Absent
Diagnosis of HF in problem list Present True ‘+’ (A) False ‘+’ (B) (A + B)
431 1300 1731
Absent False ‘–’ (C) True ‘–’ (D) (C + D)
362 203 662 204 024
Total (A + C) (B + D) (A + B + C + D)
793 204 962 205 755
95% Confidence interval
Sensitivity A/(A+C) 54.4% 54.1%–54.6%
Specificity D/(B+D) 99.4% 99.3%–99.4%
Likelihood ratio ‘+’ 85.7
Likelihood ratio ‘–’ 0.5
Positive predictive value A/(A+B) 24.9% 24.7%–25.1%
Negative predictive value D/(C+D) 99.8% 99.8%–99.8%
TPFN ratio 1.2
DBFind10 000 17.6
LVEF = left ventricular ejection fraction
TPFN = true positive to false negative
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the behavioural component of data entry. Physician
attention to coding completeness and accuracy may
be expected to increase with growing appreciation of
the potential uses of clinical databases.
Finally, the most accurate data may be compiled
through the aggregation of multiple data sources. In
this study of a heart failure population, combining the
EHR problem list data with electronic LVEF values
from the cardiology laboratory would be expected to
provide the most valid identification strategy. EHRs
are capable of importing clinical data, such as LVEF
values, from external sources. The routine application
of such interfaces should enhance validity.
This study has several limitations. The gold stand-
ard for defining a diagnosis of systolic dysfunction
was a measured LVEF. As a result appropriately coded
instances of diastolic dysfunction, in the presence 
of preserved or unmeasured systolic function, are
deemed false positives. At the time of this analysis, HF
diagnosis in the EHR problem list was incapable 
of distinguishing isolated diastolic dysfunction from
systolic dysfunction, as there were no differentiating
ICD-9-CM codes. The most recent revisions to the
ICD-9-CM system now include codes specific for
systolic (428.2x), diastolic (428.3x) and combined
systolic and diastolic heart failure (428.4x).12 Adoption
of these newly revised codes in both clinical and
administrative applications will benefit quality
improvement, disease management and research
initiatives. This study also was not designed to
quantify occult systolic dysfunction, so problem list
inaccuracy associated with undiagnosed heart failure
remains undetermined. Finally, the criteria used to
identify active patients are arbitrary, and this may
have resulted in the inclusion of some patients no
longer receiving care in PRN clinics.
Although the potential utility of accurate patient
problem lists for such activities as disease manage-
ment has been discussed, the implications of problem
list inaccuracy in conventional practice remain undeter-
mined. This may be elucidated through comparison
of patterns of drug utilisation between patients in the
true positive and false negative categories. It will be
beneficial to determine whether false negative patients
are less likely to receive valuable therapies, such as
ACE inhibitors, beta blockers and spironolactone, or
more likely to receive relatively contraindicated therapies,
such as non-steroidal anti-inflammatory agents and
dihydropyridine calcium channel antagonists.
Conclusion
In conclusion, the results of this validation study of
EHR-stored patient problem list data in the primary
care setting are disappointing. Assessment of accuracy
is an important step in the evolving application of
EHR data to patient care, disease management,
clinical research and related activities. EHR database
validity may be enhanced through integration with
other clinical data sources. The ramifications of in-
complete and inaccurate EHR databases are unknown
and merit investigation.
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